KARUNA THERAPEUTICS INC (KRTX)
US48576A1007 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 185.82M | 248.30M | 207.00M | 53.00M | 208.90M | |||
| Marketable Securities | 1.08B | 875.70M | 287.00M | 269.30M | 180.50M | |||
| Receivables | 0.00 | 100.00K | 1.80M | N/A | N/A | |||
| Other Current Assets | 52.50M | 30.70M | 21.60M | 22.30M | 3.30M | |||
| Total Current Assets | 1.32B | 1.15B | 517.30M | 344.60M | 392.70M | |||
| Non-Current Assets | ||||||||
| PPE Net | 20.51M | 7.90M | 9.50M | 2.90M | 200.00K | |||
| Other Non-Current Assets | 382.00K | 700.00K | 800.00K | 200.00K | 100.00K | |||
| Total Non-Current Assets | 20.90M | 8.50M | 10.40M | 3.00M | 300.00K | |||
| TOTAL ASSETS | 1.34B | 1.16B | 527.70M | 347.60M | 393.00M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 44.45M | 31.60M | 18.30M | 6.00M | 2.40M | |||
| Accounts Payable | 6.78M | 2.40M | 1.90M | 900.00K | 500.00K | |||
| Other Current Liabilities | 16.89M | N/A | N/A | N/A | 0.00 | |||
| Total Current Liabilities | 68.13M | 33.90M | 20.20M | 6.90M | 3.00M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 13.85M | 3.20M | 5.40M | 1.80M | 200.00K | |||
| Total Non-Current Liabilities | 13.85M | 3.20M | 5.40M | 1.80M | 100.00K | |||
| TOTAL LIABILITIES | 81.97M | 37.10M | 25.60M | 8.70M | 3.10M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -997.89M | -564.20M | -287.90M | -144.10M | -75.50M | |||
| Additional Paid In Capital | 2.26B | 1.69B | 790.40M | 483.00M | 465.40M | |||
| Common Shares | 4.00K | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Treasury Stock | -4.52M | N/A | N/A | N/A | N/A | |||
| Other Shareholders' Equity | 211.00K | -3.30M | -500.00K | 0.00 | 0.00 | |||
| Shares Outstanding | 38.08M | 34.50M | 29.80M | 27.00M | 26.00M | |||
| Tangible Book Value per Share | 32.94 | 32.64 | 16.85 | 12.55 | 15.00 | |||
| Total Shareholders' Equity | 1.25B | 1.13B | 502.00M | 338.90M | 389.90M | |||
| TOTAL LIABILITIES AND EQUITY | 1.34B | 1.16B | 527.70M | 347.60M | 393.00M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 19.31 | 34.06 | 25.61 | 49.94 | 130.90 | |||
| Return On Assets (ROA) | -32.46% | -23.75% | -27.25% | -19.72% | -11.19% | |||
| Return On Equity (ROE) | -34.58% | -24.54% | -28.65% | -20.23% | -11.27% | |||
All data in USD